Submission | General Principles | Study Ethics | Clinical Trial Registration | Structure and Language | The Title and Author | Abstract and Keywords | Main Text | Conflicts of Interest | Acknowledgments | Funding Sources | Preparation of Tables and Figures | References | Copyright Notice | Publication Fee | Revision of Manuscript | Acceptance Letter | Plagiarism
Author should first register as Author and/or is offered as Reviewer through the following address: http://greenmedicaljournal.umi.ac.id/index.php/gmj/user/register
Author should fulfill the form as detail as possible where the star marked form must be entered. After all form textbox was filled, Author clicks on “Register” button to proceed the registration. Therefore, Author is brought to online author submission interface where Author should click on “New Submission”. In the Start a New Submission section, click on “’Click Here’: to go to step one of the five-step submission process”.
The following are five steps in online submission process:
Step 1 - Starting the Submission: select the Journal Section (Full Article), tick all of the checklist
Step 2 – Uploading the Submission: To upload a manuscript to this journal, click Browse on the Upload submission file item and choose the manuscript document file to be submitted, then click Upload button. Please make sure that the manuscript file has been uploaded.
Step 3 – Entering Submission’s Metadata: In this step, detail authors metadata should be entered including marked corresponding author. After that, manuscript title and abstract must be uploaded by copying the text and paste in the textbox including keywords.
Step 4 – Uploading Supplementary Files: Supplementary file should be uploaded including Covering/Submission Letter, Statements, and ethical clearance in PDF format. Therefore, click on Browse button, choose the files, and then click on Upload button.
Step 5 – Confirming the Submission: Author should final check the uploaded manuscript documents in this step. To submit the manuscript to GMJ, click Finish Submission button after the documents is true. The corresponding author or the principal contact will receive an acknowledgement by email and will be able to view the submission’s progress through the editorial process by logging in to the journal web address site.
After this submission, Author who submits the manuscript will get a confirmation email about the submission. Therefore, Author is able to track his submission status at anytime by logging in to the online submission interface. The submission tracking includes status of manuscript review and editorial process.
In submitting manuscripts to GMJ, authors should take special note that manuscripts must conform to all GMJ style requirements. The authors should follow the requirements for citations and references, figures, and tables. The manuscripts that do not follow the requirement of GMJ may be returned to authors for modification.
The work should not have been published or submitted for publication elsewhere, and free plagiarism. All articles submitted will be conducted plagiarism checking through Turnitin software program.
Authors must also supply:
1. ICMJE conflicts of interest statement form
2. Copy of ethical approval (when needed), and
3. Final checklist signed by all author(s).
A cover letter should be provided along with the submission addressed to the Editor-in-chief of UMI Medical Journal which should include a statement about all previous submissions of the manuscript and previous reports that might be regarded as redundant publication of the work. If the manuscript has been submitted previously to another journal, authors are encouraged to provide previous comments along with the responses to accelerate the review process. Author(s) also have to mention the work whether it has been presented in a congress/conference/seminar.
Templates are available for original articles, review article and case reports.
All submitted papers containing animal experiments and/or involving human subjects should have obtained approval from an independent ethics committee. The copy of approval should be provided to the editorial office as mentioned above.
The authors are encouraged to register all clinical trials to the publicly accessible registration in any registry as recommended by ICMJE or integrated to WHO International Clinical Trials Registry Platform (ICTRP) or in ClinicalTrials.gov, which is a data provider to the WHO ICTRP. The trial registration number should be provided at the end of the abstract. The registration should be done prior to the conduct of the trial.
All papers submitted to the journal should be written in English. Manuscripts should be typed using word processors (Microsoft Word or Open Office) software. The font used throughout the paper is Times New Roman 12. The paper size is A4, one-column format with a 2.54 cm for all margins, 1.5 space, except the title and abstract use one space. The paper is limited up to 13 pages.
The title should be accurate, unambiguous, specific, complete and not be a summarization of results or conclusion but describe the research or topic of the paper. Do not contain infrequently-used abbreviations.
The title of the paper should be in 12 pt bold Times New Roman and be centered. The title should have 0 pts space above and 12 pts below. Upright, Max. 14 Words, Bold, single-spaced, Capital Letter Every Word Beginning, except the preposition and conjunction.
Author(s) names are written without title and professional positions such as Prof, Dr, Production Manager, etc. Do not abbreviate your last/family name. Always give your First and Last names. Write a clear affiliation of all Authors. Affiliation includes the name of department/unit, (faculty), name of university, address, country. Please indicate Corresponding Author (include address for mailing service, telephone number, e-mail address, and mobile phone number) by adding an asterisk (*) in superscript before the name.
Author names should be in 12 pt Times Roman bold with 12 pts above and 12 pts below. Author addresses are superscripted by numerals and centered over one columns of manuscripts. Author affiliations should be in 12 pt Times Roman. The body of the text should commence 2 lines (24 points) below the last address.
The Abstract is written in English with word limitation 150 to 250 words, single-spaced. It should be prepared in one paragraph covers introduction (1-2 sentences), objectives (1 sentence), method (3-5 sentences), results (3-5 sentences), conclusions (1 sentence). Keywords are limited to 3-6 words or short phrases (capital letters only found in the first keyword, separated by semicolons (;) and not ending periods in the last keyword). For instance: Cattle; import; indigenous; malaria; Plasmodium sp
In this the problem set out to be resolved must be mentioned, the theoretical framework on which it is based, if relevant, previous publications, the current situation and the importance or implications that the solution has for the study subjects and/or the health system, and it must end with statement of the objectives and/or hypothesis. It will be as brief as possible, and its basic rule is to provide the basic information necessary for the reader to be able to understand the text that follows later. All of this supported with the most current and important literature references. State the specific purpose or research objective of, or hypothesis tested by, the study or observation. Cite only directly pertinent references, and do not include data or conclusion from the work being reported.
An exhaustive description must be provided on how the study has been performed, with sufficient information so that other researchers can replicate it; that is, that they can perform it without consulting the authors. Its content will be determined by the objectives of the study. It will contain several subsections that do not need to be specified in the text:
1. Design: The type of study performed must be mentioned, justifying, if necessary, the reasons for its choice.
2. Population and Study Setting: Indicate the place and the date of performing the study. Specify the characteristics of the studied population and the inclusion and exclusion criteria. If all the population has not been studied, it must indicate how the sample size was calculated and the value of the parameters used, as well as the sampling technique.
3. Variables: Define all the variables that have been collected, determined by the objectives established, particularly the variables of the most important results. If it is an experimental study, it must mention the intervention made (also of the control group, if relevant and the follow-up time.
4. Data collection: Explain how the data have been collected and who did it, as well as the tools used for this purpose, indicating if they are validated and the corresponding literature reference.
5. Data Analysis: Mention the statistics program used for the analysis and the analysis performed. Indicate the strategy used for the literature review, that is, data bases reviewed, the descriptors or keywords employed in the search and the years reviewed.
6. Ethical Aspects: It must be specified, in the case of research studies, whether it has been approved by the corresponding Ethics Committee, and whether it complies with the requirement established in national and international guidelines for clinical trials and similar studies as applicable.
Present your result in logical sequence in the text, tables and figures, giving the main or most important finding first. It must only include the most important results, according to the objectives and the statistical analysis mentioned in the Method section. The results must respond exactly to the objectives that have been established and must make clear whether or not they certify the working hypothesis. There should not be any objective in the in-troduction that is not given a response in the results and any objective not mentioned in the introduction should not have a response in the results. Assessments or comments on the results obtained should also not be included in this section.In general, it should start with a description of the study subjects, to specifically know the number studied and their characteristics. If, subjects have been lost during the study, or it has not been able to contact, with the total of the sample selected, it must also indicate both the number and the reason.After the description of the subjects, a descriptive analysis of the most important variables will be presented, according to the measurement scale, and the most suitable manner to describe them will be chosen, attempting to provide the best information about each one (thus, frequencies and percentages will be used for the nominal qualitative variables, and for the quantitative ones, mean and standard deviation when they follow a normal distribution, etc.). The corresponding confidence intervals will also be indicated.
If there is more than one study group, each one must be characterised, and later indicate the comparisons between these groups in terms of statistical significance an magnitude of the difference and, above all, in terms of clinical relevance. Statistical tests that have not been described in the Method section must not be employed, and their results must be accompanied by a statistical value, degrees of freedom and statistical significance (P value), and the confidence interval (where appropriate). To indicate the P value, it is advisable not to use more than 3 decimals (P=.002); thus, a value of P=.000001 may be expressed as P<.001. Tables and/or Figures can be used to complement the information, not to duplicate it. Do not repeat all the data in the table or figure in the text. The Tables and Figures must be sufficiently clear to be able to interpret them with the need to refer to the text. If abbreviations or initials are used, they must be explained in the Table or Figure footnotes.
Separate reporting of data by demographic variables, such as age and sex, facilitating pooling of data for subgroups across studies and should be routine, unless there are compelling reasons not to stratify reporting, which should be explained.
It is useful to begin the discussion by briefly summarizing the main findings, and explore possible mechanisms or explanations for these findings. Emphasize the new and important aspects of your study and put your findings in the context of the totality of the relevant evidence. In this section, the authors must express their opinions on study topic and the results obtained, avoiding repetition of the information that has been given in the Results or in the Introduction. Comparison should be made with the results obtained in other studies, with the corresponding literature references. Mention should be made of the possible limitations of the study that could determine the interpretation of the results. State the implications of your findings for future research and for clinical practice or policy.
Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data. In particular, distinguish between clinical and statistical significance, and avoid making statements on economic benefits and costs unless the manuscript includes the appropriate economic data and analyses. Avoid claiming priority or alluding to work that has not been completed. State new hypotheses when warranted, but label them clearly. The conclusions and the appropriate recommendations will be reflected, as well as suggestions for future studies on the topic and the implications that it has for the practice
Conflicts of interest should be transparent as detail as possible as provided in the ICMJE form as a standardized authors’ disclosures. Financial and personal relationships are easily identifiable that might bias or be seen to bias the work. Funding sources for the work should be described specifically with explanations of the role of those sources and the authors should declare that the supporting sources had no involvement in specific role. The authors should declare that the authors had access to all the study and the sponsors did not intervene the data or the work. Each author should submit a separate form from ICMJE.
Personal acknowledgments should be limited to appropriate professionals who contributed to the paper, including technical help and financial or material support, also general support by a department chairperson.
Funding sources for the work should be described specifically with explanations of the role of those sources and the authors should declare that the supporting sources had no involvement into nor influence on the content of the manuscript. This statement should be written separately and limited to the funding for the work. If funder(s) had any impact into or influence on the design; data collection, management, analysis and interpretation of the data, the preparation, review, or approval of the manuscript or the decision to submit the manuscript for publication, their role must be disclosed in detail.